Lack of cardiovascular side effects of the new tricyclic antidepressant tianeptine: a double-blind, placebo-controlled study in young healthy volunteers

In a double-blind, placebo-controlled, crossover study, the effects of therapeutic doses of the new tricyclic antidepressant tianeptine on cardiovascular function were closely monitored in 21 healthy volunteers during a 2-week treatment period. Blood pressure measurements, ECG recording, 24-h Holter...

Ausführliche Beschreibung